Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Total Non-Current Liabilities (2016 - 2025)

Conmed's Total Non-Current Liabilities history spans 16 years, with the latest figure at $1.2 billion for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 2.26% year-over-year to $1.2 billion; the TTM value through Dec 2025 reached $1.2 billion, down 2.26%, while the annual FY2025 figure was $1.2 billion, 2.26% down from the prior year.
  • Total Non-Current Liabilities reached $1.2 billion in Q4 2025 per CNMD's latest filing, down from $1.2 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $1.4 billion in Q2 2023 to a low of $937.6 million in Q4 2021.
  • Average Total Non-Current Liabilities over 5 years is $1.2 billion, with a median of $1.3 billion recorded in 2024.
  • Peak YoY movement for Total Non-Current Liabilities: skyrocketed 44.76% in 2023, then decreased 7.5% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $937.6 million in 2021, then skyrocketed by 43.81% to $1.3 billion in 2022, then dropped by 0.27% to $1.3 billion in 2023, then fell by 6.51% to $1.3 billion in 2024, then decreased by 2.26% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Total Non-Current Liabilities are $1.2 billion (Q4 2025), $1.2 billion (Q3 2025), and $1.2 billion (Q2 2025).